Purpose Pharmacokinetic considerations in patients who have undergone Roux-en-Y gastric bypass (RYGB ... decreasing stomach size) with malabsorption (bypassing the entire duodenum).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback